These include nausea, diarrhea, vomiting, constipation, and stomach pain
For an intravitreal injection of ranibizumab (Lucentis, Genentech) for diabetic macular edema (DME), the indicated dosage is 0.3 mg, and the HCPCS code J2778 descriptor is injection, ranibizumab, 0.1 mg
Delivered to your door Your medication is approved and delivered quickly in discreet packaging
Conflict of interest The authors declared no potential conflicts of interest concerning this articles research, authorship, and/or publication
The experimental protocol was performed 4 days after previous acclimatization
Specifically, outcomes were defined by the presence of at least one ICD code recorded in the clinical records during the follow-up period